Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesVoiding dysfunction and hysterectomy
Current Urology Reports, 09/09/09
Jayne C et al. – The understanding of surgical techniques and surgical innovations has also improved. Knowledge, understanding, and innovation have led to speculation regarding a cause and effect relationship of hysterectomy to lower urinary tract symptoms. Unfortunately, results of the publications since Hanley’s have been inconsistent and despite our advances since 1969, only continue to lead to speculation.
Related Articles
Modified Radical Hysterectomy Versus Extrafascial Hysterectomy in the Treatment of Stage I Endometrial Cancer: Results From the ILIADE Randomized Study
Annals of Surgical Oncology, 10/20/09
Relevance Score: 94%
Laparoscopic subtotal hysterectomy versus laparoscopic total hysterectomy: a decade of experience
Gynecological Surgery, 11/18/09
Relevance Score: 93%
Nationwide Use of Laparoscopic Hysterectomy Compared With Abdominal and Vaginal Approaches
Obstetrics and Gynecology, 10/27/09
Relevance Score: 91%
Peripartum hysterectomy in Turkey: A case-control study
Journal of Obstetrics and Gynaecology, 10/27/09
Relevance Score: 89%
Laparoscopic radical hysterectomy with lymphadenectomy in patients with early cervical cancer: Our instruments and technique
Surgical Oncology, 11/05/09
Relevance Score: 88%
Today in Voiding Dys/Incontinence...keeping you current
Receive free subspecialty "5-minute updates" via email
Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder
Urology, 12/09/09
Lower urinary tract symptoms, obesity and the metabolic syndrome
Current Opinion in Urology, 12/09/09
Does the combination of an [alpha]1-adrenergic antagonist with a 5[alpha]-reductase inhibitor improve urinary symptoms more than either monotherapy
Current Opinion in Urology, 12/09/09
Article Search
Sponsor